[Can coronary "restenosis" after percutaneous angioplasty be prevented?].
Juliard
J M
JM
Himbert
D
D
Steg
P G
PG
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D001241:Aspirin / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control* / Q000601:surgery; D003328:Coronary Thrombosis / Q000209:etiology / Q000517:prevention & control*; D003329:Coronary Vasospasm / Q000517:prevention & control; D005395:Fish Oils / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D010982:Platelet-Derived Growth Factor / Q000502:physiology; D012008:Recurrence; D012307:Risk Factors; D014859:Warfarin / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D005395:Fish Oils; D010982:Platelet-Derived Growth Factor; D014859:Warfarin; D006493:Heparin; D001241:Aspirin
Peut-on prévenir la "resténose" coronaire après angioplastie percutanée?